Xconomy

OCTOBER 7, 2016

The firm will now focus on its miniLab, which CEO Elizabeth Holmes touted as a follow-on version of its Edison test system at a scientific conference in August. The funding could be as much as $100 million, and the first grants will be announced in 2017. She refused to discuss Edison at the time. —The U.S. THE ENVELOPE, PLEASE.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

JUNE 17, 2016

Data from a hematology conference stoked dreams of approval, though still on a far horizon, for a couple drug makers. Despite technical differences and the early nature of the data that made comparison difficult, Wall Street declared Spark this week’s winner. You think a Game 7 in the NBA Finals is going to be epic? .

News 55

News Technical Review Conference Report 55

Xconomy

JULY 15, 2016

All eyes are on Holmes, who is scheduled to present data from the company’s technology at a medical conference on August 1. million Series A to develop a drug, licensed from Columbia University, for the brain cancer glioblastoma… Lyndra , a Cambridge startup working on oral drug delivery technology, has received $5.4

News 40

News Technical Review San Diego Startup 40